Target Healthcare REIT (LON:THRL – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as GBX 117 and last traded at GBX 113.40, with a volume of 132837 shares changing hands. The stock had previously closed at GBX 113.36.
Analyst Upgrades and Downgrades
Separately, Jefferies Financial Group reissued a “hold” rating and issued a GBX 101 price target on shares of Target Healthcare REIT in a research note on Wednesday. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of GBX 101.
Read Our Latest Research Report on Target Healthcare REIT
Target Healthcare REIT Stock Up 1.1%
About Target Healthcare REIT
Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.
Further Reading
- Five stocks we like better than Target Healthcare REIT
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
